Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals and CRISPR Therapeutics are researching the use of gene editing to develop potential new treatments aimed at the underlying genetic causes of human disease, including transfusion-dependent β-thalassemia and severe sickle cell disease.